Arrowhead Presents New Clinical Data Demonstrating a Sustained Host Response in Hepatitis B Patients Following … – Nanotechnology News (press release)

Arrowhead Presents New Clinical Data Demonstrating a Sustained Host Response in Hepatitis B Patients Following ...Nanotechnology News (press release)Bruce D. Given, M.D., chief operating officer and head of R&D for Arrowhead Pharmaceuticals, said: "We ...
Continue reading » · Written on: 12-07-17 · No Comments »